Arch Biopartners Inc. (ARCH.V)
CAD 1.7
(-2.86%)
CAD 1.7
(-2.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -234.07 Thousand | -1.08 Million | -2.98 Million | -1.9 Million | -1.8 Million | -3.19 Million |
| Net Income | -3.32 Million | -1.08 Million | -1.16 Million | -4.62 Million | -2.09 Million | -3.19 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.95 Million | 24.97 Thousand | 109.6 Thousand | 1.72 Million | 83.1 Thousand | 1.13 Million |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 1.13 Million | -24.97 Thousand | -1.92 Million | 996.68 Thousand | 204.95 Thousand | 3.19 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -5.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 559 Thousand | -421.37 Thousand | 2.77 Million | 2.15 Million | 1.66 Million | 2.65 Million |
| Debt repayment | -1 Million | -775 Thousand | -425 Thousand | -488 Thousand | -1.42 Million | -1.07 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 128 Thousand | 369.93 Thousand | 1.04 Million | 1.67 Million | 221.17 Thousand | 1.58 Million |
| Other Financing Activities | 1.43 Million | -16.3 Thousand | 2.15 Million | 976 Thousand | 2.86 Million | 1.07 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 506.34 Thousand | 448.24 Thousand | 653.68 Thousand | 400.36 Thousand | 544.32 Thousand | 42.58 Thousand |
| Cash at end of period | 831.27 Thousand | 506.34 Thousand | 448.24 Thousand | 653.68 Thousand | 400.36 Thousand | 544.32 Thousand |
| Capital Expenditure | -5.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 324.92 Thousand | 58.1 Thousand | -205.44 Thousand | 253.31 Thousand | -143.95 Thousand | 501.74 Thousand |
| Free Cash Flow | -234.08 Thousand | -1.08 Million | -2.98 Million | -1.9 Million | -1.8 Million | -3.19 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -884.56 Thousand | -1.14 Million | -783.25 Thousand | 244.28 Thousand | -3.32 Million | -450.78 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 579.98 Thousand | - | 1.95 Million | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 20.45 Thousand | 683.14 Thousand | -343.07 Thousand | -1.09 Million | 1.13 Million | 2.32 Million |
| Investing Cash Flow | - | - | - | 1.35 Million | - | -1.35 Million |
| Investments in PPE | 3.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | 1.35 Million | - | -1.35 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 901.5 Thousand | 169.3 Thousand | 17.69 Thousand | 289.54 Thousand | 559 Thousand | 121 Thousand |
| Debt repayment | -124.5 Thousand | -3198.00 | -17.69 Thousand | -491 Thousand | -1 Million | -1.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -201.45 Thousand | - | - |
| Common Stock Issuance | 762.5 Thousand | 172.5 Thousand | - | -201.45 Thousand | 128 Thousand | 128 Thousand |
| Other Financing Activities | 901.5 Thousand | -7000.00 | 35.39 Thousand | 982 Thousand | 1.43 Million | 1.5 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 6560.00 | 302.63 Thousand | 14.74 Thousand | 1.39 Million | 506.34 Thousand | 708.48 Thousand |
| Cash at end of period | 43.94 Thousand | 6560.00 | 302.63 Thousand | 831.27 Thousand | 831.27 Thousand | 1.39 Million |
| Capital Expenditure | 3.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | -1.35 Million | - | 40 Thousand |
| Net cash flow / Change in cash | 37.38 Thousand | -296.07 Thousand | 287.89 Thousand | -565.86 Thousand | 324.92 Thousand | 688.65 Thousand |
| Free Cash Flow | -864.11 Thousand | -465.37 Thousand | -546.33 Thousand | -855.4 Thousand | -234.07 Thousand | 1.87 Million |
TN8
002545
300188
KKKUF
000852
SIXD